The long-term neurodevelopmental outcomes of toddlers with SARS-CoV-2 infection in the neonatal period: a prospective observational study
- PMID: 38413995
- PMCID: PMC10900707
- DOI: 10.1186/s13052-024-01609-w
The long-term neurodevelopmental outcomes of toddlers with SARS-CoV-2 infection in the neonatal period: a prospective observational study
Abstract
Background: The effect of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus in the neonatal period on developing brain is still unknown. This study aims to investigate the long-term neurodevelopmental outcomes of newborns exposed to SARS-CoV-2 & Delta variant.
Methods: At a tertiary referral center, a prospective observational cohort research was carried out. All babies who were equal to or more than 34 gestational weeks gestation and were admitted to the NICU between January 2021 and January 2022 due to SARS-CoV-2 infection (Delta - or Delta +) were included in the study. Infants who were hospitalized for non-SARS-CoV-2 reasons at similar dates and who had no history of invasive mechanical ventilation were incorporated as a control group using a 2:1 gender and gestational age match. Thirty infants were assigned to the study group and sixty newborns to the control group based on the sample size calculation. These toddlers' neurodevelopment was evaluated between the ages of 18 and 24 months using the Bayley-II scale.
Results: We enrolled 90 infants. SARS-CoV-2-positive infants had poorer psychomotor development index (PDI) scores and significantly greater mildly delayed performances (MDPs) at 18-24 months (PDI p = 0.05, MDPs p = 0.03, respectively). Delta variant showed statistically significant lower MDI and PDI scores (MDI p=0.03, PDI p=0.03, respectively). A smaller head circumference of SARS-CoV-2-positive toddlers was detected in the first year (p < 0.001), which improved at the second age.
Conclusion: SARS-CoV-2-positive neonates revealed lower PDI scores and greater MDPs at 18th-24th months. The effect is most noticeable in Delta variant. Longer-term examination of neurodevelopmental outcomes and reevaluation of these children between the ages of 5 and 12 are critical.
Keywords: Bayley-II; Neurodevelopment; Newborn; SARS-CoV-2.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy.JAMA Netw Open. 2023 Apr 3;6(4):e237396. doi: 10.1001/jamanetworkopen.2023.7396. JAMA Netw Open. 2023. PMID: 37036706 Free PMC article.
-
Long-Term Growth and Neurodevelopmental Outcomes of Neonates Infected with SARS-CoV-2 during the COVID-19 Pandemic at 18-24 Months Corrected Age: A Prospective Observational Study.Neonatology. 2024;121(4):450-459. doi: 10.1159/000537803. Epub 2024 Apr 5. Neonatology. 2024. PMID: 38583433 Free PMC article.
-
Neurodevelopment in infants with antenatal or early neonatal exposure to SARS-CoV-2.Early Hum Dev. 2022 Dec;175:105694. doi: 10.1016/j.earlhumdev.2022.105694. Epub 2022 Nov 12. Early Hum Dev. 2022. PMID: 36402122
-
Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review.J Perinatol. 2008 Dec;28 Suppl 3:S93-101. doi: 10.1038/jp.2008.154. J Perinatol. 2008. PMID: 19057618 Review.
-
Effects of intrauterine exposure to SARS-CoV-2 on infants' development: a rapid review and meta-analysis.Eur J Pediatr. 2023 May;182(5):2041-2055. doi: 10.1007/s00431-023-04910-8. Epub 2023 Mar 11. Eur J Pediatr. 2023. PMID: 36899144 Free PMC article. Review.
Cited by
-
Post-discharge Care Practices, Challenges, and Outcomes in Newborn Infants of Mothers With SARS-CoV-2 Infection: Insights From Public Hospitals.Cureus. 2024 Apr 22;16(4):e58734. doi: 10.7759/cureus.58734. eCollection 2024 Apr. Cureus. 2024. PMID: 38779231 Free PMC article.
-
How to Manage a Neonate Born from a SARS-CoV-2-Positive Mother: A Narrative Review.Pathogens. 2024 Nov 8;13(11):977. doi: 10.3390/pathogens13110977. Pathogens. 2024. PMID: 39599530 Free PMC article. Review.
References
-
- Baccarella A, Linder A, Spencer R, Alexander J, Jonokuchi PB, King A, Maldonado-Soto, et al. Increased intracranial pressure in the setting of multisystem infammatory syndrome in children, associated with COVID-19. Pediatr Neurol. 2021;115:48–9. doi: 10.1016/j.pediatrneurol.2020.11.008. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous